Imidazole → 2-(1H-imidazol-1-yl)-6-(2-(1-methyl-4-phenyl-1H-imidazol-2-yl)-vinyl)pyridine
Reaction equation
Br[C:2]1[CH:7]=[CH:6][CH:5]=[C:4]([CH:8]=[CH:9][C:10]2[N:11]([CH3:21])[CH:12]=[C:13]([C:15]3[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=3)[N:14]=2)[N:3]=1.[NH:22]1[CH:26]=[CH:25][N:24]=[CH:23]1.C([O-])([O-])=O.[K+].[K+]>CN(C)C=O.[Cu]I>[N:22]1([C:2]2[CH:7]=[CH:6][CH:5]=[C:4]([CH:8]=[CH:9][C:10]3[N:11]([CH3:21])[CH:12]=[C:13]([C:15]4[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=4)[N:14]=3)[N:3]=2)[CH:26]=[CH:25][N:24]=[CH:23]1Participants
6
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
2-Bromo-6-(2-(1-methyl-4-phenyl-1H-imidazol-2-yl)vinyl)pyridine (102 mg, 0.3 mmol), imidazole (41 mg, 0.6 mmol), CuI (6 mg, 0.03 mmol), and K2CO3 (124 mg, 0.9 mmol) were mixed in dimethylformamide (2 mL). The resulting solution was heated for 5 h in a microwave reactor held at a constant temperature of 160° C. The crude product was purified using reverse phase column chromatography to give 2-(1H-imidazol-1-yl)-6-(2-(1-methyl-4-phenyl-1H-imidazol-2-yl)-vinyl)pyridine (57 mg). MS (ESI): m/z 328 [M+H]+.
Workup
- temperatureThe resulting solution was heated for 5 h in a microwave reactor
- customheld at a constant temperature of 160° C
- customThe crude product was purified
Sources & evidence
- ORD record
- ord-7de6bea8937142719fafc030dd474ebf
- Source dataset
- uspto-grants-2015_03
- Patent number
- US08969349B2
Reaction notes
Loading…